More on LRMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.2 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Larimar Therapeutics (NQ:LRMR)
Delayed: 4.00 -0.01 (0.25%)
Prev. Close $4.01  
Open$4.03 
52 Wk High$ 
52 Wk Low$ 
Day High$4.16 
Day Low$3.98 
P/E N/A  
EPS$ 
Volume1,230,997 

Friends, Peers and Foes (?): KBLB, META, MVRS, VIR, GSGN (more...)

Jul 8, 2026 04:05 PM Form 4 Larimar Therapeutics, For: Jul 06 Filed by: Hamilton Thomas Edward
Jul 7, 2026 05:21 AM Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens
Jul 2, 2026 06:05 AM H.C. Wainwright Assumes Larimar Therapeutics (LRMR) at Buy
Jun 30, 2026 06:54 AM Larimar Therapeutics (LRMR) PT Lowered to $5 at Baird
Jun 29, 2026 06:34 AM Form 8-K Larimar Therapeutics, For: Jun 29
Jun 29, 2026 06:30 AM Larimar files first BLA module for Friedreich's ataxia drug
Jun 29, 2026 06:30 AM Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
Jun 26, 2026 04:05 PM Larimar Therapeutics to host investor event on June 29
Jun 26, 2026 04:05 PM Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
May 27, 2026 01:09 AM JPMorgan Starts Larimar Therapeutics (LRMR) at Overweight
View All Articles

Entities mentioned with LRMR

View All Entities